Literature DB >> 16716443

Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings.

Sudha Cugati1, Annette Kifley, Paul Mitchell, Jie Jin Wang.   

Abstract

PURPOSE: To compare the age-specific prevalence of diabetes and diabetic retinopathy (DR) over 6 years.
METHODS: The Blue Mountains Eye Study (BMES) examined 3654 residents (82.4% response) aged >49 years in BMES I (1992-1994). Survivors (n = 2335) and newly eligible residents (n = 1174) were examined in BMES II (1997-2000). Diabetes was defined by history or fasting plasma glucose > or =7.0 mmol/L. DR was graded from 6-field retinal photographs using the Airlie House Classification. Age-specific prevalence in 5-year intervals was compared, as samples of each age group were independent.
RESULTS: The overall diabetes prevalence increased from 7.8 to 9.9% (p = 0.002) while the age-specific prevalence increased in age groups 60-74 years, over 6 years. A slightly higher prevalence of mild levels of DR (p = 0.018) but lower prevalence of moderate-severe levels of DR (p = 0.049) was evident in BMES II compared to BMES I. Factors significantly associated with DR prevalence were diabetes duration > or =20 years (BMES I, OR 7.6 [2.9-20.5]; BMES II, OR 6.1 [2.5-15.4]) and blood glucose level (BMES I, OR 1.1 [1.0-1.2]; BMES II, OR 1.2 [1.1-1.3] per mmol/L increase).
CONCLUSIONS: An increased prevalence of diabetes, but decreased prevalence of severe levels of DR, was documented in two survey samples from the same region over 6 years.

Entities:  

Mesh:

Year:  2006        PMID: 16716443     DOI: 10.1016/j.diabres.2006.04.002

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

2.  Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999-2002 and 2005-2008.

Authors:  Fang Ko; Susan Vitale; Chiu-Fang Chou; Mary Frances Cotch; Jinan Saaddine; David S Friedman
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

3.  Report on the creation of a diabetes register and retinopathy screening outcomes in the Mid-West of Ireland.

Authors:  M James; C Goodchild; S Bashir; M Mannix
Journal:  Ir J Med Sci       Date:  2015-01-17       Impact factor: 1.568

4.  Are individuals with diabetes seeing better?: a long-term epidemiological perspective.

Authors:  Ronald Klein; Barbara E K Klein
Journal:  Diabetes       Date:  2010-08       Impact factor: 9.461

Review 5.  Current epidemiology of diabetic retinopathy and diabetic macular edema.

Authors:  Jie Ding; Tien Yin Wong
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

6.  Prevalence and associated factors of diabetic retinopathy in rural Korea: the Chungju metabolic disease cohort study.

Authors:  Ji-Hyun Kim; Hyuk-Sang Kwon; Yong-Moon Park; Jin-Hee Lee; Man-Soo Kim; Kun-Ho Yoon; Won Chul Lee; Bong-Yun Cha; Ho-Young Son
Journal:  J Korean Med Sci       Date:  2011-07-30       Impact factor: 2.153

Review 7.  Current concepts in diabetic retinopathy.

Authors:  Su Jeong Song; Tien Yin Wong
Journal:  Diabetes Metab J       Date:  2014-12       Impact factor: 5.376

8.  Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.

Authors:  G Bhanuprakash Reddy; A Satyanarayana; N Balakrishna; Radha Ayyagari; M Padma; K Viswanath; J Mark Petrash
Journal:  Mol Vis       Date:  2008-03-24       Impact factor: 2.367

Review 9.  Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant.

Authors:  Zafer Cebeci; Nur Kir
Journal:  Diabetes Metab Syndr Obes       Date:  2015-11-16       Impact factor: 3.168

10.  The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey.

Authors:  Durgul Acan; Mehmet Calan; Duygu Er; Tugba Arkan; Nilufer Kocak; Firat Bayraktar; Suleyman Kaynak
Journal:  BMC Ophthalmol       Date:  2018-04-12       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.